ICU Medical, Inc. (ICUI) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↓
14.13
↓-63% vs avg
5yr avg: 38.15
30Y Low6.4·High81.9
P/FCF
↑
38.22
+18% vs avg
5yr avg: 32.48
30Y Low12.6·High83.5
P/B Ratio
↓
1.65
↓-15% vs avg
5yr avg: 1.95
30Y Low1.1·High4.0
ROE
↓
0.0%
↓+104% vs avg
5yr avg: -0.9%
30Y Low-6%·High16%
Debt/EBITDA
↑
4.28
↓-62% vs avg
5yr avg: 11.29
30Y Low0.2·High36.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ICUI Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
ICU Medical, Inc. trades at 4774.5x earnings, 95% above its 5-year average of 2451.4x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 21484%. On a free-cash-flow basis, the stock trades at 38.2x P/FCF, 18% above the 5-year average of 32.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.5B | $3.6B | $3.8B | $2.4B | $3.8B | $5.2B | $4.6B | $4.0B | $5.0B | $4.5B | $2.5B |
| Enterprise Value | $4.6B | $4.6B | $5.1B | $3.9B | $5.3B | $4.7B | $4.3B | $3.8B | $4.6B | $4.2B | $2.1B |
| P/E Ratio → | 4774.49 | 4852.72 | — | — | — | 50.07 | 53.36 | 39.90 | 172.65 | 65.65 | 40.26 |
| P/S Ratio | 1.57 | 1.59 | 1.59 | 1.06 | 1.65 | 3.93 | 3.64 | 3.18 | 3.54 | 3.49 | 6.70 |
| P/B Ratio | 1.65 | 1.67 | 1.93 | 1.13 | 1.80 | 3.20 | 3.08 | 2.93 | 3.93 | 3.76 | 3.85 |
| P/FCF | 38.22 | 38.70 | 30.36 | 33.13 | — | 27.74 | 37.85 | — | 83.46 | 60.28 | 38.88 |
| P/OCF | 19.51 | 19.76 | 18.55 | 14.46 | — | 19.32 | 20.79 | 39.56 | 30.96 | 29.18 | 28.27 |
P/E links to full P/E history page with 30-year chart
ICUI EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
ICU Medical, Inc.'s enterprise value stands at 14.1x EBITDA, 63% below its 5-year average of 38.1x. This is roughly in line with the Healthcare sector median of 14.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.08 | 2.15 | 1.71 | 2.32 | 3.54 | 3.37 | 3.00 | 3.30 | 3.26 | 5.53 |
| EV / EBITDA | 14.13 | 14.27 | 112.72 | 15.31 | 27.49 | 20.95 | 22.21 | 20.62 | 47.90 | 81.86 | 20.56 |
| EV / EBIT | 42.94 | 42.72 | 126.26 | 157.71 | — | 37.54 | 43.20 | 32.96 | 23.41 | 79.04 | 24.59 |
| EV / FCF | — | 50.51 | 41.05 | 53.11 | — | 25.01 | 35.04 | — | 77.65 | 56.40 | 32.07 |
ICUI Profitability
Margins and return-on-capital ratios measuring operating efficiency
ICU Medical, Inc. earns an operating margin of 4.8%. Operating margins have expanded from 1.0% to 4.8% over the past 3 years, signaling improving operational efficiency. ROE of 0.0% is modest. ROIC of 2.5% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% |
| Operating Margin | 4.8% | 4.8% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 1.5% | -1.2% | 21.9% |
| Net Profit Margin | 0.0% | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.0% | 0.0% | -5.8% | -1.4% | -4.0% | 6.6% | 6.0% | 7.7% | 2.3% | 7.4% | 10.2% |
| ROA | 0.0% | 0.0% | -2.7% | -0.7% | -2.3% | 5.7% | 5.0% | 6.2% | 1.9% | 6.2% | 9.5% |
| ROIC | 2.5% | 2.5% | 0.9% | 0.5% | -1.4% | 8.2% | 6.4% | 7.8% | 1.8% | -2.0% | 27.1% |
| ROCE | 3.0% | 3.0% | 1.1% | 0.6% | -1.5% | 7.6% | 6.5% | 7.7% | 1.6% | -1.5% | 13.3% |
ICUI Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
ICU Medical, Inc. carries a Debt/EBITDA ratio of 4.3x, which is highly leveraged (33% above the sector average of 3.2x). Net debt stands at $1.1B ($1.4B total debt minus $308M cash). Interest coverage of just 1.0x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.66 | 0.66 | 0.84 | 0.80 | 0.83 | 0.03 | 0.04 | 0.03 | — | — | — |
| Debt / EBITDA | 4.28 | 4.28 | 36.16 | 6.77 | 9.02 | 0.20 | 0.27 | 0.20 | — | — | — |
| Net Debt / Equity | — | 0.51 | 0.68 | 0.68 | 0.73 | -0.31 | -0.23 | -0.17 | -0.27 | -0.24 | -0.67 |
| Net Debt / EBITDA | 3.34 | 3.34 | 29.36 | 5.76 | 7.93 | -2.28 | -1.78 | -1.26 | -3.58 | -5.63 | -4.36 |
| Debt / FCF | — | 11.81 | 10.69 | 19.99 | — | -2.72 | -2.81 | — | -5.80 | -3.88 | -6.81 |
| Interest Coverage | 1.03 | 1.03 | 0.38 | 0.24 | -0.62 | 144.72 | 56.62 | 209.94 | 278.08 | 26.05 | 722.73 |
ICUI Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
ICU Medical, Inc.'s current ratio of 2.36x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.13x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.53x to 2.36x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.36 | 2.36 | 2.59 | 2.53 | 2.50 | 5.13 | 4.68 | 3.55 | 3.72 | 4.11 | 14.04 |
| Quick Ratio | 1.13 | 1.13 | 1.54 | 1.06 | 1.09 | 3.68 | 3.07 | 2.19 | 2.47 | 2.74 | 12.82 |
| Cash Ratio | 0.62 | 0.62 | 0.55 | 0.53 | 0.43 | 2.83 | 2.10 | 1.18 | 1.53 | 1.43 | 10.98 |
| Asset Turnover | — | 0.55 | 0.57 | 0.52 | 0.50 | 0.70 | 0.72 | 0.75 | 0.88 | 0.86 | 0.54 |
| Inventory Turnover | 2.29 | 2.29 | 2.66 | 2.14 | 2.27 | 2.84 | 2.57 | 2.35 | 2.67 | 3.00 | 3.61 |
| Days Sales Outstanding | — | 29.55 | 31.06 | 29.43 | 39.53 | 34.61 | 36.69 | 58.29 | 51.21 | 42.11 | 56.87 |
ICUI Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
ICU Medical, Inc. returns 0.2% to shareholders annually primarily through share buybacks. The earnings yield of 0.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.0% | 0.0% | — | — | — | 2.0% | 1.9% | 2.5% | 0.6% | 1.5% | 2.5% |
| FCF Yield | 2.6% | 2.6% | 3.3% | 3.0% | — | 3.6% | 2.6% | — | 1.2% | 1.7% | 2.6% |
| Buyback Yield | 0.2% | 0.2% | 0.3% | 0.4% | 0.0% | 0.0% | 0.3% | 0.5% | 0.1% | 0.1% | 0.7% |
| Total Shareholder Yield | 0.2% | 0.2% | 0.3% | 0.4% | 0.0% | 0.0% | 0.3% | 0.5% | 0.1% | 0.1% | 0.7% |
| Shares Outstanding | — | $25M | $24M | $24M | $24M | $22M | $22M | $22M | $22M | $21M | $17M |
Peer Comparison
Compare ICUI with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ICUIYou | $4B | 4774.5 | 14.1 | 38.2 | 36.8% | 4.8% | 0.0% | 2.5% | 4.3 |
 BDX | $52B | 24.7 | 14.0 | 19.5 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 ITGR | $3B | 31.5 | 13.5 | 29.8 | 23.1% | 11.3% | 6.1% | 5.4% | 4.2 |
 AVA | $3B | 16.7 | 10.3 | — | 24.2% | 18.0% | 7.3% | 4.5% | 5.3 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 MMSI | $4B | 31.6 | 14.0 | 18.6 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 ANGO | $505M | -14.6 | — | — | 53.9% | -13.7% | -17.5% | -22.9% | — |
 NXRT | $684M | -21.4 | 18.0 | 8.2 | 84.3% | 11.1% | -8.9% | 1.1% | 12.6 |
 MCK | $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ICUI — Frequently Asked Questions
Quick answers to the most common questions about buying ICUI stock.
What is ICU Medical, Inc.'s P/E ratio?
ICU Medical, Inc.'s current P/E ratio is 4774.5x. The historical average is 37.1x. This places it at the 100th percentile of its historical range.
What is ICU Medical, Inc.'s EV/EBITDA?
ICU Medical, Inc.'s current EV/EBITDA is 14.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.2x.
What is ICU Medical, Inc.'s ROE?
ICU Medical, Inc.'s return on equity (ROE) is 0.0%. The historical average is 8.7%.
Is ICUI stock overvalued?
Based on historical data, ICU Medical, Inc. is trading at a P/E of 4774.5x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are ICU Medical, Inc.'s profit margins?
ICU Medical, Inc. has 36.8% gross margin and 4.8% operating margin.
How much debt does ICU Medical, Inc. have?
ICU Medical, Inc.'s Debt/EBITDA ratio is 4.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.